{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:04:20Z","timestamp":1789513460979,"version":"build-2803163510"},"reference-count":75,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Von Willebrand disease (VWD) is the most common inherited bleeding disorder, caused by quantitative or qualitative defects in von Willebrand factor (VWF). Diagnosis is challenging and requires integrating bleeding history, VWF antigen and activity measurements, FVIII assays, and specialized phenotyping. Genetic testing is increasingly recognized as a key component. Here, we review current concepts in VWD diagnostics and highlight the Spanish Clinical and Molecular Profile of von Willebrand Disease (PCM-EVW-ES) project as a model for genomics-enabled precision medicine. PCM-EVW-ES is a multicenter initiative involving 48 hospitals, centralized phenotypic testing, and next-generation sequencing of the VWF coding region, enabling definitive classification in 730 individuals with VWD to date. Harmonized recruitment criteria and standardized workflows improve subtype assignment, uncover complex genotypes, refine genotype\u2013phenotype correlations, and facilitate the identification of asymptomatic carriers. The PCM-EVW-ES variant spectrum highlights recurrent disease-causing variants in Spain and underscores the value of coordinated national registries for variant curation. Building on these data, we propose a diagnostic algorithm in which bleeding assessment and first-line VWF\/FVIII assays, combined with, early VWF molecular testing increases diagnostic accuracy and guides targeted second-line investigations to confirm and refine VWD subtype classification. We also outline persisting challenges, including the interpretation of variants of uncertain significance and patients without identifiable pathogenic VWF variants, and future directions integrating third-generation sequencing, expanded gene panels, functional studies, and artificial-intelligence-driven multiomic approaches. Together, these advances illustrate how robust multicenter studies can bridge the gap between complex diagnostics and clinical practice in VWD.<\/jats:p>","DOI":"10.1055\/a-2845-0281","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:37:51Z","timestamp":1776292671000},"page":"869-880","source":"Crossref","is-referenced-by-count":0,"title":["Integrating Next-Generation Sequencing into von Willebrand Disease Diagnostics: Insights from the PCM-EVW-ES Multicenter Project"],"prefix":"10.1055","volume":"52","author":[{"given":"Nina","family":"Borr\u00e0s","sequence":"additional","affiliation":[{"name":"Laboratori de Coagulopaties Cong\u00e8nites, Banc de Sang i Teixits, Barcelona, Spain"},{"name":"Medicina Transfusional, Vall d'Hebron Institut de Recerca, Universitat Aut\u00f2noma de Barcelona (VHIR-UAB), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Corrales","sequence":"additional","affiliation":[{"name":"Laboratori de Coagulopaties Cong\u00e8nites, Banc de Sang i Teixits, Barcelona, Spain"},{"name":"Medicina Transfusional, Vall d'Hebron Institut de Recerca, Universitat Aut\u00f2noma de Barcelona (VHIR-UAB), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vidal","sequence":"additional","affiliation":[{"name":"Laboratori de Coagulopaties Cong\u00e8nites, Banc de Sang i Teixits, Barcelona, Spain"},{"name":"Medicina Transfusional, Vall d'Hebron Institut de Recerca, Universitat Aut\u00f2noma de Barcelona (VHIR-UAB), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of PCM-EVW-ES Investigators Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"F Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"E J Werner","year":"1993","journal-title":"J Pediatr"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"J E Sadler","year":"2000","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-024-00536-8","article-title":"von Willebrand disease","volume":"10","author":"O Seidizadeh","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor","volume":"4","author":"J E Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"P D James","year":"2021","journal-title":"Blood Adv"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"D Ginsburg","year":"1985","journal-title":"Science"},{"issue":"33","key":"ref8","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"D J Mancuso","year":"1989","journal-title":"J Biol Chem"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/jth.12093","article-title":"Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 genomes","volume":"11","author":"Q Y Wang","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"D J Mancuso","year":"1991","journal-title":"Biochemistry"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Y F Zhou","year":"2012","journal-title":"Blood"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.2023021915","article-title":"Novel functions for von Willebrand factor","volume":"144","author":"F Atiq","year":"2024","journal-title":"Blood"},{"issue":"09","key":"ref13","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"F Rodeghiero","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1055\/s-0040-1713636","article-title":"The effect of age on von Willebrand factor and bleeding symptoms in von Willebrand disease","volume":"120","author":"C D Seaman","year":"2020","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"J C Gill","year":"1987","journal-title":"Blood"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"e2013052","DOI":"10.4084\/mjhid.2013.052","article-title":"Changes of von Willebrand factor during pregnancy in women with and without von Willebrand disease","volume":"5","author":"G Castaman","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/asheducation-2016.1.670","article-title":"What have we learned from large population studies of von Willebrand disease?","volume":"2016","author":"R R Montgomery","year":"2016","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1073\/pnas.86.10.3723","article-title":"Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA","volume":"86","author":"D Ginsburg","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.13175","article-title":"Molecular diagnosis of von Willebrand disease","volume":"23","author":"L Baronciani","year":"2017","journal-title":"Haemophilia"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1160\/TH08-08-0500","article-title":"Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene","volume":"101","author":"I Corrales","year":"2009","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2011.055285","article-title":"High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods","volume":"97","author":"I Corrales","year":"2012","journal-title":"Haematologica"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3324\/haematol.2017.168765","article-title":"Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients","volume":"102","author":"N Borr\u00e0s","year":"2017","journal-title":"Haematologica"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/hae.70075","article-title":"Integrating next-generation sequencing into routine molecular diagnosis of inherited coagulation factor deficiencies: real-world data from Spanish patients","volume":"31","author":"N Borr\u00e0s","year":"2025","journal-title":"Haemophilia"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12908","article-title":"Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders","volume":"22","author":"J M Bastida","year":"2016","journal-title":"Haemophilia"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/hae.14438","article-title":"Molecular study of a large cohort of 109 haemophilia patients from Cuba using a gene panel with next generation sequencing-based technology","volume":"28","author":"N Borr\u00e0s","year":"2022","journal-title":"Haemophilia"},{"issue":"08","key":"ref26","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.jtha.2025.04.026","article-title":"Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders","volume":"23","author":"R Ramanan","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"102686","DOI":"10.1016\/j.rpth.2025.102686","article-title":"Challenges and considerations of genetic testing in von Willebrand disease","volume":"9","author":"O Seidizadeh","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"05","key":"ref28","first-page":"630","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"A Cumming","year":"2006","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"109","author":"A Goodeve","year":"2007","journal-title":"Blood"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"P D James","year":"2007","journal-title":"Blood"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles","volume":"11","author":"M Bowman","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"21","key":"ref32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1182\/blood.V122.21.332.332","article-title":"The complete type I VWD cohort of the Zimmerman Program for the molecular and clinical biology of VWD - phenotypic assignment, mutation frequency, and bleeding assessment","volume":"122","author":"R R Montgomery","year":"2013","journal-title":"Blood"},{"issue":"21","key":"ref33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood.V124.21.472.472","article-title":"Spectrum of type 2 Von Willebrand disease in the Zimmerman Program","volume":"124","author":"V H Flood","year":"2014","journal-title":"Blood"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"e3038","DOI":"10.1097\/MD.0000000000003038","article-title":"A laboratory phenotype\/genotype correlation of 1167 French patients from 670 families with von Willebrand disease: a new epidemiologic picture","volume":"95","author":"A Veyradier","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"01","key":"ref35","first-page":"17","article-title":"Genotype-phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS","volume":"116","author":"T Fidalgo","year":"2016","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref36","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1160\/TH16-10-0794","article-title":"Molecular and clinical profile of VWD in a large cohort of Chinese population: application of next generation sequencing and CNVplex technique","volume":"117","author":"Q Liang","year":"2017","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0039-1678528","article-title":"Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): results from the BRNO-VWD Study","volume":"119","author":"I Vangenechten","year":"2019","journal-title":"Thromb Haemost"},{"issue":"15","key":"ref38","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/bloodadvances.2020003397","article-title":"Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS","volume":"5","author":"L Baronciani","year":"2021","journal-title":"Blood Adv"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1097\/HS9.0000000000000718","article-title":"Importance of genotyping in von Willebrand disease to elucidate pathogenic mechanisms and variability in phenotype","volume":"6","author":"F Atiq","year":"2022","journal-title":"HemaSphere"},{"issue":"07","key":"ref40","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jth.15713","article-title":"Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program","volume":"20","author":"P A Christopherson","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1055\/s-0042-1757635","article-title":"Analysis of von Willebrand disease in the \u201cHeart of Europe\u201d","volume":"6","author":"I Vangenechten","year":"2022","journal-title":"TH Open"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jtha.2024.06.026","article-title":"Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study","volume":"22","author":"A Krahforst","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-0031-1281036","article-title":"Diagnosis and management of von Willebrand disease in Spain","volume":"37","author":"J Batlle","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1160\/TH15-04-0282","article-title":"Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): proposal for a new diagnostic paradigm","volume":"115","author":"J Batlle","year":"2016","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref45","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1182\/bloodadvances.2024012626","article-title":"Type 2M\/2A von Willebrand disease: a shared phenotype between type 2M and 2A","volume":"8","author":"O Seidizadeh","year":"2024","journal-title":"Blood Adv"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1538-7836.2008.02853.x","article-title":"Type 2M von Willebrand disease: a variant of type 2A?","volume":"6","author":"J Batlle","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajh.20470","article-title":"von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia)","volume":"80","author":"N Penas","year":"2005","journal-title":"Am J Hematol"},{"issue":"S 02","key":"ref48","doi-asserted-by":"publisher","first-page":"102503","DOI":"10.1016\/j.rpth.2024.102503","article-title":"Update on the VWD clinical and molecular profile project in Spain (PCM-EVW-ES): outcomes from the second recruitment phase","volume":"8","author":"N Borr\u00e0s","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"05","key":"ref49","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0036-1579638","article-title":"Type 2B von Willebrand disease: a matter of plasma plus platelet abnormality","volume":"42","author":"G Castaman","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref50","doi-asserted-by":"crossref","first-page":"e92575","DOI":"10.1371\/journal.pone.0092575","article-title":"Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients","volume":"9","author":"P Kasatkar","year":"2014","journal-title":"PLoS One"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0033-1334867","article-title":"Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update","volume":"39","author":"A B Federici","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"20","key":"ref52","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1182\/blood-2011-10-387548","article-title":"von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion","volume":"119","author":"S R Madabhushi","year":"2012","journal-title":"Blood"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0039-3400260","article-title":"The current understanding of molecular pathogenesis of quantitative von Willebrand disease, types 1 and 3","volume":"40","author":"H Yadegari","year":"2020","journal-title":"Hamostaseologie"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"102451","DOI":"10.1016\/j.rpth.2024.102451","article-title":"Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease","volume":"8","author":"O Seidizadeh","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"02","key":"ref55","first-page":"552","article-title":"Q1311X: a novel nonsense mutation of putative ancient origin in the von Willebrand factor gene","volume":"111","author":"P Casa\u00f1a","year":"2000","journal-title":"Br J Haematol"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/jth.14341","article-title":"Defective collagen binding and increased bleeding in a murine model of von Willebrand disease affecting collagen IV binding","volume":"17","author":"T L Slobodianuk","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1111\/hae.13156","article-title":"VWF collagen (types III and VI)-binding defects in a cohort of type 2M VWD patients - a strategy for improvement of a challenging diagnosis","volume":"23","author":"T Fidalgo","year":"2017","journal-title":"Haemophilia"},{"issue":"04","key":"ref58","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12185-019-02814-8","article-title":"Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience","volume":"111","author":"M Rassoulzadegan","year":"2020","journal-title":"Int J Hematol"},{"issue":"02","key":"ref59","first-page":"156","article-title":"Landscape and spectrum of VWF variants in type 2 Von Willebrand disease: insights from a German patient cohort","volume":"126","author":"H Yadegari","year":"2026","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"102730","DOI":"10.1016\/j.rpth.2025.102730","article-title":"Clinical utility of panel-based genetic sequencing for von Willebrand disease","volume":"9","author":"R Ramanan","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and genomics and the association for molecular pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"issue":"11","key":"ref62","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/humu.23645","article-title":"ClinGen variant curation expert panel experiences and standardized processes for disease and gene-level specification of the ACMG\/AMP guidelines for sequence variant interpretation","volume":"39","author":"E A Rivera-Mu\u00f1oz","year":"2018","journal-title":"Hum Mutat"},{"issue":"04","key":"ref63","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1538-7836.2011.04204.x","article-title":"The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes","volume":"9","author":"I Corrales","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3324\/haematol.2018.203166","article-title":"Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA","volume":"104","author":"N Borr\u00e0s","year":"2019","journal-title":"Haematologica"},{"issue":"14","key":"ref65","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2012-06-434373","article-title":"Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease","volume":"121","author":"J W Wang","year":"2013","journal-title":"Blood"},{"issue":"01","key":"ref66","first-page":"28","article-title":"Evaluating seven bioinformatics platforms for tertiary analysis of genomic data from whole exome sequencing in a pilot group of patients","volume":"6","author":"N Bastida-Lertxundi","year":"2025","journal-title":"Adv Lab Med"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41597-024-03327-8","article-title":"Analysis of AlphaMissense data in different protein groups and structural context","volume":"11","author":"H Tordai","year":"2024","journal-title":"Sci Data"},{"issue":"03","key":"ref68","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"K Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/ijms23063095","article-title":"A homozygous deep intronic variant causes von Willebrand factor deficiency and lack of endothelial-specific secretory organelles, Weibel-Palade bodies","volume":"23","author":"H Yadegari","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"04","key":"ref70","doi-asserted-by":"crossref","first-page":"102888","DOI":"10.1016\/j.rpth.2025.102888","article-title":"Genetic analysis using long-read sequencing to overcome the difficulties in VWF gene","volume":"9","author":"S Ye","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"07","key":"ref71","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ejhg.2016.21","article-title":"Genome-wide association studies identify genetic loci for low von Willebrand factor levels","volume":"24","author":"J van Loon","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"18","key":"ref72","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood.2023021452","article-title":"A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels","volume":"143","author":"P S de Vries","year":"2024","journal-title":"Blood"},{"issue":"05","key":"ref73","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.118.034532","article-title":"Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels","volume":"139","author":"M Sabater-Lleal","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"ref74","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium","volume":"121","author":"N L Smith","year":"2010","journal-title":"Circulation"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jth.12927","article-title":"CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease","volume":"13","author":"Y V Sanders","year":"2015","journal-title":"J Thromb Haemost"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2845-0281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:44:48Z","timestamp":1789512288000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2845-0281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":75,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2026,9,15]]},"published-print":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2845-0281","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}